What development phase is IOFETAMINE HYDROCHLORIDE I 123 in?

IOFETAMINE HYDROCHLORIDE I 123 is FDA-approved (marketed).

Last reviewed 2026-05-14 · How we verify

IOFETAMINE HYDROCHLORIDE I 123

FDA-approved approved Small molecule Quality 2/100

At a glance

Generic name	IOFETAMINE HYDROCHLORIDE I 123
Modality	Small molecule
Phase	FDA-approved
First approval	1987

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

IOFETAMINE HYDROCHLORIDE I 123 CI brief — competitive landscape report
IOFETAMINE HYDROCHLORIDE I 123 updates RSS · CI watch RSS